Virtu Financial LLC Vericel Corp Transaction History

Virtu Financial LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 19, 2021	SELL	$30.93 - $59.48 $245,213 - $471,557	-7,928 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$18.53 - $31.5 $146,905 - $249,732	7,928 New	7,928 $245,000
Q2 2019 Aug 13, 2019	SELL	$15.01 - $18.89 $255,395 - $321,413	-17,015 Closed	0 $0
Q1 2019 Apr 12, 2019	SELL	$16.23 - $20.29 $821,968 - $1.03 Million	-50,645 Reduced 74.85%	17,015 $298,000
Q1 2018 May 14, 2018	BUY	$5.7 - $12.3 $385,662 - $832,218	67,660 New	67,660 $673,000
Q4 2017 Feb 09, 2018	SELL	$3.65 - $5.98 $118,460 - $194,080	-32,455 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$3.0 - $6.0 $97,365 - $194,730	32,455	32,455 $0

277

48.8M

91.8K

23.2K

Ticker VCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,178,000
Market Cap $2.73B
Description
Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.